Unraveling the role of β1 integrin isoforms in cRGD-mediated uptake of nanoparticles bearing hydrophilized alkyne moieties in epithelial and endothelial cells
Source abstract
Abstract
The uptake and trafficking of NPs is impacted by several attributes such as size, shape, surface charge and importantly by surface ligands that can interact with the cell plasma membrane. We envision that NPs which can be readily modified in aqueous environments will be key to engineering patient-specific nanotherapeutics. Towards such systems that can be functionalized "on demand" in aqueous environments, an α-ω epoxy ester monomer that bears an alkyne group at the end of an oligoethylene glycol moiety was designed and synthesized. Copolymerization of this monomer with ε-caprolactone yielded polymers that present hydrophilized alkyne groups along the backbone. This enabled the direct modification of the surface of NPs, as suspensions in aqueous phase, with cell interaction peptides such cyclic-arginine-glycine-aspartic acid (cRGD) using the "click reaction". Uptake of cRGD modified NPs (cRGD-NPs) in human endothelial and tumor epithelial cells revealed that cRGD surprisingly diminished uptake in both tumor epithelial and microvascular endothelial cells by 40-50 percent in comparison to unmodified particles. Probing the mechanism of uptake revealed that the expression pattern of two isoforms of β1 integrin impacted the uptake of cRGD-NPs differently. While the expression of high molecular weight 140 kDa form of the β1 integrin enhanced NP uptake, the expression of low molecular 120 kDa form had an inhibitory effect. Furthermore, although, the expression of β3 integrin was enhanced in endothelial cells and breast cancer epithelial cells, no correlation between β3 integrin and NP uptake was observed. Additionally, in presence of clathrin and caveolae pathway inhibitors the uptake of cRGD-NPS was in general diminished with a 25-75% decrease in presence of Filipin, a caveolae inhibitor; suggesting a role for lipid rafts in the β1 integrin-mediated uptake of cRGD-NP NPs. In sum, the polymer system described can be readily adapted to engineer other targeting peptide-based nanotherapeutics, especially for the delivery across difficult penetrate biological barriers such as the blood brain barrier. The main findings of this study have significant implication for the development of integrin targeted nanotherapeutics for anti-tumor therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cell Adhesion Molecules Research · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Engineered nanomedicines with enhanced tumor penetration10.1016/j.nantod.2019.100800 ↗
2. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
3. Nanomaterials for cancer therapy and imaging10.1007/s10059-011-0051-5 ↗
4. Nanomaterials: applications in cancer imaging and therapy
5. Cell-specific aptamers for targeted therapies10.1007/978-1-59745-557-2_5 ↗
6. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells10.1158/0008-5472.CAN-04-2550 ↗
7. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer10.2967/jnumed.109.069880 ↗
8. Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae10.1073/pnas.1322356111 ↗
9. Enhanced cellular uptake of nanoparticles by increasing the hydrophobicity of poly(lactic acid) through copolymerization with cell-membrane-lipid components10.1039/C5CC06397C ↗
10. Liposomal treatment of cancer cells modulates uptake pathway of polymeric nanoparticles by altering membrane stiffness10.1002/smll.201704245 ↗
11. Renal clearance of polymeric nanoparticles by mimicry of glycan surface of viruses10.1016/j.biomaterials.2019.119643 ↗
12. Clickable degradable aliphatic polyesters via copolymerization with alkyne epoxy esters: synthesis and postfunctionalization with organic dyes10.1021/ja505629w ↗
13. Clickable" polymersomes10.1039/b704568a ↗
14. Triazole cycloaddition as a general route for functionalization of Au nanoparticles10.1021/cm060157b ↗
15. Toward the syntheses of universal ligands for metal oxide surfaces: controlling surface functionality through click chemistry10.1021/ja064041s ↗
16. Functionalization of silica nanoparticles via the combination of surface-initiated RAFT polymerization and click reactions10.1021/ma801551z ↗
17. Click chemistry as a route to surface functionalization of polymer particles dispersed in aqueous media10.1039/b821758k ↗
18. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis10.1021/mp3002733 ↗
19. Substrate engagement of integrins alpha(5)beta(1) and alpha(v)beta(3) is necessary, but not sufficient, for high directional persistence in migration on fibronectin
20. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency10.1021/bc900167c ↗
21. A comprehensive evaluation of the activity and selectivity profile of ligands for RGD-binding integrins10.1038/srep39805 ↗
22. beta1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy10.4161/cam.20077 ↗
23. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo
24. Surface modification of RGD-liposomes for selective drug delivery to monocytes/neutrophils in brain10.1248/cpb.55.1192 ↗
25. Single-step process to produce surface-functionalized polymeric nanoparticles10.1021/la701997x ↗
26. Hydrophilization of poly(caprolactone) copolymers through introduction of oligo(ethylene glycol) moieties10.1371/journal.pone.0099157 ↗
27. Mechanistic study of the reactivity of 3,4-epoxycyclohexyl methyl 3′,4′-epoxycyclohexancarboxylate in photoinitiated cationic polymerizations10.1002/pola.1995.080331421 ↗
28. Caveolae/raft-dependent endocytosis10.1083/jcb.200302028 ↗
29. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms10.1034/j.1600-0854.2003.00128.x ↗
30. Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover10.1242/jcs.014977 ↗
31. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif10.1016/0968-0004(91)90096-E ↗
32. Evidence for the presence of a low-mass beta1 integrin on the cell surface10.1242/jcs.02520 ↗
33. Effects of particle size and ligand density on the kinetics of receptor-mediated endocytosis of nanoparticles10.1063/1.3293303 ↗
34. Integrin alpha(V)beta(3) binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor10.1128/JVI.01673-07 ↗
35. Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery10.1039/C6CS00076B ↗